1. Introduction {#sec1}
===============

Phenolic compounds have been well investigated for their disease prevention and health promoting effects based on epidemiological studies using both *in-vitro* and *in-vivo* methods ([@bib116]; [@bib55]; [@bib29]). Most of them have been used in traditional medicine formulation and in pharmaceutical preparations ([@bib11]; [@bib112]). They comprise of a wide range of compounds from simple phenols to complex polyphenols, such as phenolic acids, flavonoids, lignans and stilbenes ([@bib65]; [@bib23]). Diarylheptanoids are complex phenolic compounds having the skeletal structure of two aromatic rings conjugated with seven carbon chains ([@bib16]; [@bib8]). They are structurally diverse and have been isolated from seeds, fruits, leaves, roots, rhizomes and barks of plants of different families such as Myricaceae, Betulaceae, Zingiberaceae, Aceraceae, Leguminosae and Burseraceae ([@bib86]; [@bib44]; [@bib37]). More than 400 diarylheptanoids have been identified till now and most compounds occur in *Zingiber*, *Betula* and *Alnus* species ([@bib117]; [@bib5]). These species exhibit characteristic aroma, and also act as colouring agents. Mostly, *Zingiber* and *Curcuma* rhizomes have been used as seasoning spices and as ingredients in folk medicines and traditional Asian medicines ([@bib54]). Organoleptic characteristics are attributed to the presence of diarylheptanoids. [@bib99] identified asadanin, a cyclic diarylhepatanoids responsible for the bitter off-taste in *Corylus avellana*.

2. Diarylheptanoids and dietary supplements {#sec2}
===========================================

Nutraceuticals are bioactive compounds or extracts with scientifically evident health benefits ([@bib18]; [@bib31]; [@bib78]). A dietary supplements, are available in the form of tablets, capsules or syrups targeting disease prevention and treatment ([@bib17]; [@bib28]). Epidemiological studies show that dietary supplementation of nutraceuticals such as catechins, linolenic acid, anthocyanin, lycopene, resveratrol and saponin glycosides can decrease the incidence of diseases ([@bib18]; [@bib10]; [@bib91]). Studies have shown that nutraceuticals have the property to inhibit prostate cancer growth ([@bib93]), protect against cardiovascular disease ([@bib101]), control cholesterol levels ([@bib22]) and andrologic disorders ([@bib107]), maintain gastrointestinal health ([@bib90]) and retard degenerative disorders ([@bib80]). Diarylheptanoids, also known as dipheylheptanoids, fall under the class of plant secondary metabolites derived from various plant sources ([Table 1](#tbl1){ref-type="table"} ). It constitutes two phenolic aromatic rings linked by a linear seven-carbon chains. It can be either open chain or macrocyclic diarylheptanoids ([Fig. 1](#fig1){ref-type="fig"} ) ([@bib46]). Studies have also shown the health benefits of diarylheptanoids. Among nutraceuticals, curcumin is an important diarylheptanoid compound, studied extensively for its role in protection against many diseases ([@bib53]). Extracts of *Alpinia officinarum* contain diarylheptanoids, and are prepared as a health supplement capsule ([@bib26]). Diarylheptanoids isolated from *Alnus glutinosa* have shown to protect non-cancerous dividing cells during cancer treatment ([@bib25]). [@bib119] showed the estrogenic activity of diarylheptanoids isolated from *C. comosa* and its role in postmenopausal hormone therapy. Cassumunarin gives excellent anti-oxidant properties ([@bib41]), Cassumunins A, B and C isolated from *Zingiber cassumunar* showed stronger antioxidant activities than that of curcumin ([@bib68]), and studies have shown the therapeutic benefits of gingerenones ([@bib103]) and platyphylloside ([@bib43]) in treating obesity (see [Table 2](#tbl2){ref-type="table"}, [Table 3](#tbl3){ref-type="table"}).Table 1Major plant sources of diarylheptanoids (Source: [@bib66]).Table 1CompoundsResource(−)-centrolobol*Centrolobium robustum*(+)-centrolobol*Centrolobium tomentosum, Centrolobium paraense*Diospongin C*Dioscorea spongiosa*Betulaplatoside Ia*Betula platyphylla*Betulaplatoside Ib(3S)-1-(3,4-dihydroxyphenyl)-7-(4-hydroxyphenyl)heptan-3-ol*Curcuma kwangsiensis*(3R)-1-(3,4-dihydroxyphenyl)-7-(4-hydroxyphenyl)heptan-3-ol(3S)-3-acetoxy-1-(3,4-dihydroxyphenyl)-7-(4-hydroxyphenyl)heptanes(3R)-3-acetoxy-1-(3,4-dihydroxyphenyl)-7-(4-hydroxyphenyl)heptanes(3S)-1,7-bis(4-hydroxyphenyl)-(6E)-6-hepten-3-ol(3R)-1-(3,4-dihydroxyphenyl)-7-phenyl-(6E)-6-hepten-3-ol1,7-bis(4-hydroxy-3-methoxyphenyl)-4,6-heptadien-3-one*Curcuma longa*1-(4-hydroxyphenyl)-7-(4-hydroxy-3-methoxyphenyl)-1,4,6-heptatrien-3-one1,7-bis(4-hydroxy-3-methoxyphenyl)-1,4,6-heptatrien-3-one1,5-dihydroxy-1,7-bis(4-hydroxyphenyl)-4,6-heptadiene-3-oneDihydrodemethoxycurcumin1-hydroxy-1-(4-hydroxyphenyl)-7-(4-hydroxy-3-methoxyphenyl)-6-hepten-3,5-dione3,5-diacetoxy-1-(3,4-dihydroxyphenyl)-7-(3,4-dihydroxy-5-methoxyphenyl)heptanes*Zingiber officinale*3,5-diacetoxy-1,7-bis(3,4-dihydroxy-5-methoxyphenyl)heptane3,5-diacetoxy-7-(3,4-dihydroxy-5-methoxyphenyl)-1-(4-hydroxy-3,5-dimethoxyphenyl)heptanes(3R,5S)-dihydroxy-1-(4-hydroxy-3-methoxyphenyl)-7-(3,4-dihydroxyphenyl)heptanes*Zingiber ottensii*Cassumunin A, B, C*Zingiber cassumunar*Juglanol A 5-O-β-[d]{.smallcaps}-xylopyranoside*Juglans mandshurica*1-(4″-methoxyphenyl)-7-(4′-hydroxyphenyl)-(E)-hept-2-ene*Pleuranhodium racemigerum*Oregonoside A, B*Alnus rubra*Epihirsutanonol*Alnus japonica*1,7-diphenyl-3,5-heptanedione*Alpinia conchigera*Katsumain A, B*Alpinia katsumadai*Letestuianin C*Aframomum letestuianum*Mistletonone*Viscum coloratum*2,3,7-trihydroxy-5-(3,4-dihydroxy-E-styryl)-6,7,8,9-tetrahydro-5H-benzocycloheptene*Amomum subulatum*16-methoxy acerogenin B 9-O-β-[d]{.smallcaps}-apiofuranosyl-6)-β-[d]{.smallcaps}-glucopyranoside*Myrica rubra*Myricanol 5-O-β-[d]{.smallcaps}-glycopyranosyl-(1--3)-β-[d]{.smallcaps}-glucopyranosideNanaone*Myrica nana*11-oxo-3,8,9,17-tetrahydroxy-\[7,0\]-metacyclophane*Corylus sieboldiana*11-oxo-3,12,17-trihydroxy-9-ene-\[7,0\]-metacyclophaneTable 2Diarylheptanoid rich plant species used in traditional medicines in different countries.Table 2TaxonPlant part usedPurpose/targetCountry/regionReferences*Alpinia officinarum*RhizomesStomach ache and coldChina[@bib13]*Alpinia galangal*; *Alpinia oxyphylla; Alpinia conchigera*Joint pain, cold and gastrointestinal disorderVietnam[@bib34]*C. longa*Gastric disorders, inflammationIndia, china and South Asian countries[@bib88]*Tacca chantrieri*Gastric ulcers, enteritis and hepatitisChina[@bib125]*Z. officinale*Headaches, nausea, rheumatism and coldIndia, China[@bib75]*Alpinia katsumadai*SeedsEmesis and gastric disordersChina[@bib62]*Alnus japonica*BarkCancer and hepatitisKorea[@bib94]; [@bib49]*Alnus nepalensis*Dysentery, stomach ache, and diarrheaIndia[@bib19]*Alnus glutinosa*Mouth, throat inflammation and skin diseasesBritain, Western Asia, North Africa, European countries[@bib94]*Alnus glutinosa*Swelling, inflammation, and rheumatismIndia[@bib94]*Alnus hirsuta*Fever, hemorrhage, alcoholism, and diarrheaKorea and China[@bib94]*Myrica esculenta*Asthma and bronchitisIndia[@bib84]*Garuga pinnata*Corneal opacity and also pulmonary infectionsIndia[@bib19]*M. rubra*Astringent, antidote, and diarrheaJapan[@bib3]*Garuga pinnata*LeafAsthmaIndia[@bib97]*A. nepalensis*Dysentery, stomach ache, and diarrheaIndia[@bib19]*Acer nikoense*Hepatic disordersJapan[@bib79]Table 3Pharmacological profile of diarylheptanoids.Table 3Fig. 1Structure of diarylheptanoids (a) open (b) macrocyclic.Fig. 1

3. Pharmacological activities of diarylheptanoid {#sec3}
================================================

Diarylheptanoid compounds possess numerous therapeutic benefits, including anti-inflammatory, anti-ulcer, anti-cathartic, anti-emetic, di-uretic, choleretic, hepato-protective, cholesterol level lowering, anti-bacterial, anti-fungal, analeptic and anti-diabetic activities. These are discussed below:

3.1. Anti-inflammatory activity {#sec3.1}
-------------------------------

Diarylheptanoids exhibit significant anti-inflammatory properties. Hirsutenone isolated from the bark of *A. japonica* could suppress early T-cell activation; thereby, inhibiting the degranulation of mast cells, making it a potential candidate for treating atopic dermatitis ([@bib40]). Cyclic diarylheptanoid, acerogenin M isolated from the methanol extract of *Acer nikoense* stem bark ([@bib4]), oregonin, a diarylheptanoid derivative isolated from *Alnus formosana* ([@bib56]) and cassumunarins A, B, and C from *Z. cassumunar* inhibit edema formation, exhibiting strong anti-inflammatory activity than curcumin ([@bib70]); diarylheptanoid, 7-(4′-hydroxy-3′-methoxyphenyl)-1-phenylhept-4-en-3-one from *A. officinarum* ([@bib121]) and cyclic diarylheptanoids isolated from the stem bark of *A. nikoense* such as acerosides B1 and B2, and aceroketosides inhibit the release of β-hexosaminidase ([@bib76]). Diarylheptanoids isolated from bark of *A. hirsuta*, especially oregonin and hirsutanonol showed high anti-inflammatory activity by inhibiting the cyclooxygenase-2 expression ([@bib61]). Similarly diarylheptanoid glycosides such as myricanol and myricanone isolated from *M. rubra* can inhibit the release of β-hexosaminidase from RBL-2H3 cells ([@bib69]). Blepharocalyxins A and B from *Alpinia blepharocalyx* exhibit inhibitory effects on nitric oxide production in endotoxin-activated murine macrophages ([@bib42]).

3.2. Anti-oxidant activity {#sec3.2}
--------------------------

Diarylheptanoids acts as potent antioxidants. Studies have reported the free oxygen radicals scavenging activity of curcumin ([@bib114]; [@bib39]; [@bib1]). Mistletonone exhibited scavenging capability both on hydroxyl radicals and superoxide anion radicals as compared with standard (−)-epigallocatechin gallate ([@bib122]). Cassumunin A, B, C and cassumunarin A, B, C isolated from *Zingiber cassumunar* are also potent antioxidants showing stronger or equal antioxidant activity as that of curcumin ([@bib77]; [@bib70]). Diarylheptanoids isolated from *Z. officinale* especially 5-\[4-hydroxy-6-(4-hydroxyphenethyl)tetrahydro-2H-pyran-2-yl\]-3- methoxybenzene-1,2-diol, 5-hydroxy-1-(4-hydroxy-3-methoxyphenyl)-7-(3,4-dihydroxyphenyl) heptan-3-one and 1,5-epoxy-3-hydroxy-1- (4,5-dihydroxy-3-methoxyphenyl)-7-(3,4-dihydroxyphenyl) heptanes are capable of scavenging superoxide anion radicals and inhibiting the formation of lipid peroxides in liver microsomes ([@bib108]).

3.3. Cytotoxicity and anti-carcinogenic activity {#sec3.3}
------------------------------------------------

Diarylheptanoids also shows cytotoxicity and anti-cancer effects. 7-(4″-hydroxy-3″-methoxyphenyl)-1-phenyl-4E-hepten-3-one and (5R)-5-methoxy-7-(4″-hydroxy-3″ methoxyphenyl)-1-phenyl-3-heptanone isolated from *A. officinarum* were proven to have potent cytotoxicity ([@bib106]). Diarylheptanoid 1-(4-hydroxy-3-methoxyphenyl)-7-(3,4-dihydroxyphenyl)-4E-en-3-heptanone caused cytotoxic effect in SH-SY5Y cells by arresting the cell cycle and inducing apoptosis ([@bib110]). (3S)-1,7-bis(4-hydroxyphenyl)-(6E)- 6-hepten-3-ol, centrolobol and (3S)-1-(3,4-dihydroxyphenyl)-7-(4-hydroxyphenyl)-(6E)-6-hepten-3-ol isolated from rhizomes of *Curcuma elata* showed cytotoxic activity against NCI---H187 cell lines ([@bib21]). Diarylheptanoids isolated from the sea grass *Cymodocea nodosa* exhibited cytotoxic activity. Cymodienol exhibited stronger effect; whereas, cymodiene showed moderate activity ([@bib52]). Rubanol from *M. rubra* showed cytotoxicity against Lun-06, Neu-04, and Bre-04 cell lines ([@bib118]). Myricanone, a cyclic diarylheptanoid, showed anti-cancer effects on cancer cell lines HeLa and PC3 ([@bib85]). Epicalyxin F and calyxin I isolated from ethanol extracts of *A. blepharocalyx* seeds exhibited potent anti-proliferative activity against human HT-1080 fibrosarcoma and murine colon 26-L5 carcinoma cells ([@bib33]; [@bib6]). Blepharocalyxins D, E isolated from the ethanol extract of *A. blepharocalyx* seeds exhibited significant anti-proliferative activity against murine colon 26-L5 carcinoma and human HT-1080 fibrosarcoma cells, with ED~50~ values of 3.61 and 9.02 μM, respectively ([@bib109]). Methanolic extract of dried fruits of *A. oxyphylla* showed potential chemo-preventive and anti-tumorigenic activities ([@bib130]). Diarylheptanoid compounds isolated from the rhizomes of *T. chantrieri* exhibited considerable cytotoxic activities against HSC-2 human oral squamous carcinoma cells than against normal human gingival fibroblasts. Other studies confirmed curcumin as a potent anticarcinogenic compound ([@bib104]; [@bib96]; [@bib81]; [@bib115]).

3.4. Anti-coagulant activity {#sec3.4}
----------------------------

Curcumin could restrict collagen and adrenaline-induced platelet aggregation *in vitro* as well as *in vivo* in rat thoracic aorta ([@bib102]). Bisdemethoxycurcumin, a derivate of curcumin, inhibited the thrombin and activated factor X activity, helping to prolong the thromboplastin time and prothrombin time effect. These are preferred to patients prone to vascular thrombosis, requiring anti-coagulant therapy ([@bib50]). 1, 7-bis (4-hydroxyphenyl)-3- hydroxy-1,3-heptadien-5-one isolated from *A. blepharocalyx* showed antiplatelet activity ([@bib27]). [@bib48] reported anti-coagulant activities of curcumin and its role in treatment of cardiovascular diseases.

3.5. *Anti*-adipogenic effect {#sec3.5}
-----------------------------

Platyphylloside isolated from *Betula platyphylla* showed potent *anti*-adipogenic activities by inhibiting adipocyte differentiation in 3T3-L1 cells ([@bib58]). Diarylheptanoids isolated from *A. hirsuta* leaves, particularly platyphyllonol-5-O-b-[d]{.smallcaps}-xylopyranoside showed high adipocyte differentiation ([@bib63]). Methanol extract of *A. japonica* fruits, especially, 4-hydroxy-alnus-3,5-dione, exhibited the significant *anti*-adipogenic effects ([@bib95]). [@bib127] extracted five different diarylheptanoids, such as *trans*-(4R,5S)-epoxy-1,7-diphenyl3-heptanone, 7-(4″-hydroxy-3″-methoxyphenyl)-1-phenylhepta-4E, 6E-dien-3-one and 5-hydroxy-1,7-diphenyl-3-heptanone, 1,7-diphenyl-4E-en3-heptanone and 5-methoxy-1,7-diphenyl-3-heptanone from the aqueous extract of *A. officinarum*; all these compounds exhibited significant differentiation-promoting activity in 3T3-L1 preadipocytes.

3.6. Anti-microbial activity {#sec3.6}
----------------------------

Diarylheptanoids have also been investigated for anti-bacterial, anti-fungal, anti-viral activities.

a\) Anti-bacterial activity.

Diarylheptanoids isolated from *A. officinarum* especially 5-hydroxy-7-(4-hydroxy-3-methoxyphenyl)-1-phenyl-3-heptanone, showed *anti*-*Helicobacter pylori* activity ([@bib57]). Curcumin can inhibit the growth of several bacteria species like *Streptococcus*, *Staphylococcus* and *Lactobacillus* ([@bib15]). It can also prevent growth of *Helicobacter pylori, in vitro* ([@bib67]). Diarylheptanoids such as gingerenones A, B and C as well as isogingerenone isolated from *Zingiber officinarum,* show moderate anti-fungal activity ([@bib32]). Cyclic diarylheptanoids garuganin I isolated from *Garuga pinnata* and *G. gamblei* exhibit anti-bacterial activity ([@bib45]), Another diarylheptanoid, 9′-Desmethylgaruganin I, isolated from *G. pinnata* showed moderate anti-microbial activity against a wide range of gram-positive and gram-negative bacteria and fungi ([@bib47]).

b\) Anti-fungal activity.

Studies have shown that ether and chloroform extracts, and the oil of *C*. *longa* have antifungal effects ([@bib12]); particularly, curcumin has anti-fungal effects ([@bib120]). Turmeric oil is found to be active against *Aspergillus flavus*, *Aspergillus parasiticus*, *Fusarium moniliforme* and *Penicillium digitatum* ([@bib38]).

c\) Anti-viral activity.

Hirsutenone exhibits strong papain-like protease inhibitory activity in suppressing the replication of the severe acute respiratory syndrome coronavirus (SARS-CoV). It can act as a potential drug target for the treatment of SARS. ([@bib82]). Curcumin inhibits epstein-barr virus key activator, Bam H fragment z left frame 1 (BZLF1) protein transcription in Raji DR-LUC cells ([@bib35]). It also shows *anti*-HIV (human immunodeficiency virus) activity by inhibiting the HIV-1 integrase needed for viral replication ([@bib73]; [@bib24]).

3.7. Anti-parasitic activity {#sec3.7}
----------------------------

Diarylheptanoids glycosides isolated from the ethyl acetate extract of *Pyrostria major* leaf show moderate *anti*-plasmodial activities; particularly (3S,5S)-3,5-dihydroxy1-(3-hydroxy-4-methoxyphenyl)-7-(4-methoxyphenyl) heptyl 3-O-β-[d]{.smallcaps}-glucopyranoside shows potential anti-leishmanial activity ([@bib14]). Studies confirm that curcumin has anti-leishmanial ([@bib51]) and anti-*Plasmodium falciparum* activity ([@bib89]). Further, studies have shown that diarylheptanoid structure related to curcumin show anti-leishmanial activity against *Leishmania* species such as *L. amazonensis*, *L. braziliensis* and *L. chagasi* through both *in vitro* and *in vivo* methods ([@bib7]).

3.8. Anti-fibrotic effect {#sec3.8}
-------------------------

Diarylheptanoids constituents of *B. platyphylla* showed anti-fibrotic effect. Particularly, the n-butanol fraction containing 1,7-bis-(4-hydroxyphenyl)-5-hepten-3-one significantly decreased the collagen content and increased the caspase-3/7 activity ([@bib60]). In another study, curcumin could suppress bleomycin-induced pulmonary fibrosis in rats ([@bib132]; [@bib87]). Dehydrohirsutanonol, an active constituent isolated from *A. firma* exhibits anti-fibrotic activity and can be recommended as a therapeutic agent for liver fibrosis ([@bib59]). Crude fractions of *Curcuma* species such as *C. aromatica, C. longa, C. caesia, C. amada and C. zedoria* with diarylheptanoids have been dialyzed and investigated for their coagulation cascade with respect to pro-coagulant activity. Results confirmed reducing clotting time, confirming its fibrino-genolytic acitivty ([@bib98]).

3.9. Hepatoprotective activity {#sec3.9}
------------------------------

Diarylheptanoids, such as epihirsutanonol and alusenone isolated from *A. japonica* show hepato-protective properties ([@bib111]). Ethyl acetate extracts of *A. hirsuta* containing diarylheptanoid glycoside, (5S)---O-methylhirsutanonol showed strong hepatoprotective effects ([@bib83]). Betulaplatosides Ia and Ib isolated from methanolic extract of *B. platyphylla* bark showed concentration dependent hepatoprotective activity ([@bib71]). Curcumin, bisdemethoxycurcumin and demethoxycurcumin exhibit strong anti-hepatotoxic activity on tacrine induced cytoxicity in human liver derived Hep G2 cells ([@bib100]).

3.10. Melanogenesis inhibitory {#sec3.10}
------------------------------

Cyclic and acyclic diarylheptanoids aceroside I and acerogenin M isolated from the ethyl acetate fraction of the methanol extract of *A. nikoense* showed melanogenesis inhibitory effects with less toxicity to the cells ([@bib2]). Methanol extracts of *M. rubra* bark exhibit potent inhibitory activity with reduction of melanin content ([@bib3]). Diarylheptanoids isolated from *A. hirsuta* such as (5R)-l,7-bis (3,4-dihydroxyphenyl)-heptane-5-O-I ∼ -D-glucoside, (5R)- 1,7-bis (3,4-dihydroxyphenyl)-heptane-5-ol, oregonin and hirsutanonol showed melanogenesis inhibitory activity ([@bib20]). Methanolic extract from the dried rhizomes of *Curcuma comosa* showed melanogenesis effect, particularly, (3R)-1,7-bis(4-hydroxyphenyl)-(6E)-6-hepten-3-ol exhibits strong inhibitory effects ([@bib72]).

3.11. Estrogenic activity {#sec3.11}
-------------------------

Diarylheptanoids isolated from *Aframomum melegueta* showed anti-estrogenic activity as compared through *in silico* approaches. Dihydrogingerenone A, dihydrogingerenone B, 3,5-diacetoxy-1-(3',4' - dihydroxyl phenyl)-7-(3″,4″-dihydroxy-5″-methoxyphenyl) heptanes are examples ([@bib30]). (3*R*) −1,7-diphenyl-(4*E*,6*E*) −4,6-heptadien-3-ol, isolated from *C. comosa* showed estrogenic activity, both *in vitro* and *in vivo,* by inducing estradiol-regulated endogenous genes in MCF-7 cells ([@bib119]).

3.12. Anti-diabetic effects {#sec3.12}
---------------------------

Diarylheptanoid 1,7-bis-(3,4-dihydroxyphenyl)-heptane-3-one-5-O-β-[d]{.smallcaps}-xylopyranoside isolated from the stem bark of *A. hirsuta* increases the glucose uptake in human hepatocarcinoma HepG2 cells and thereby improves glucose metabolism ([@bib36]). Curcumin decreases advanced glycation end-product induced complications in diabetes mellitus ([@bib92]). Studies also prove that it decreases blood sugar level in alloxan-induced diabetes in rat ([@bib9]). It can also prevent galactose-induced cataract formation at very low doses ([@bib105]).

3.13. Other bioactivities of diarylheptanoid {#sec3.13}
--------------------------------------------

Diarylheptanoids also possess various other potential pharmacological activities. Anti-ulcerogenic studies have shown gastroprotective and antiulcerogenic effect of curcumin by induction of angiogenesis in the granular tissue of ulcers. It has excellent therapeutic potential in restoration of *Helibacter pylori* induced gastric damage ([@bib113]; [@bib74]). Curcumin inhibits 5 alpha reductase activity, normally involved in the conversion of testosterone to 5*a*-dihydrotestosterone ([@bib64]). It affects the mobility of human spermatozoa and its function *in vitro* and *in vivo* fertility ([@bib131]). Studies have demonstrated the potential of curcumin for the development of a novel intravaginal contraceptive ([@bib126]). Diarylheptanoids isolated from *D. spongiosa* such as diospongin B and C are found to exhibit anti-osteoporotic activity by inhibiting the release of ^45^Ca on the resorption of bone tissues, the same was compared with standard drug elcitonin ([@bib123]). The aqueous extract of *D. spongiosa* exhibits significant induction of osteoblast proliferation, also inhibiting osteoclast formation against less cytotoxicity in osteoblast and bone marrow cells ([@bib124]).

4. Conclusion {#sec4}
=============

There is an increasing awareness and expectancy for safe and healthy foods among public, and this has been the driving force for the incorporation of bioactive compounds in food matrices. Diarylheptanoids have a wide spectrum of health-promoting properties and are also an indispensable component in a variety of pharmaceutical, medicinal and cosmetic applications. They are found to be a key bioactive ingredient in traditional and folk medicines formulation for treating various diseases. They can be used as alternative sources for therapeutics/nutraceuticals. Further research is needed to best utilize diarylheptanoids in diet, with the focus to promote human health and wellness.
